Product Code: LI_182004
Electronic prescribing or e-prescribing is a digital application that securely provides bidirectional electronic information exchange between payers/PBMs, pharmacies, prescribing providers, directly or through an intermediary network. E-prescribing includes routing prescriptions that ensures prescribed drug against the patient's health formulary of covered drugs, obtains prior authorization, gains any known patient drug allergies, identifiesany drug-drug interactions, provides access to patients' medication history from external sources, and sends or receives acknowledgement of prescriptions filled. The major capability of e-prescribing is to support important process in care delivery, such as medication management, medication reconciliation, and prior authorization, this in turn is driving the e-prescribing market growth.
Factors that drive the growth of the global e-prescribing market include rise in focus of developed government initiatives and incentive programs toward adoption of e-prescribing solutions, rise in focus on the reduction of fraud and abuse of controlled substances, and increase in need to curtail escalating healthcare costs. However, e-prescribing solutions are costly to integrate in the EHR or HIT systems and rise in concerns associated with security & workflow of digital healthcare records are major factors that hinder the e-prescribing market growth. Furthermore, increase in development of healthcare infrastructure and rise in adoption of e-prescribing in the developing countries across Asia-Pacific are opportunistic factors of the global e-prescribing market.
The e-prescribingmarketis segmented on the basis of component,deployment,end user, and region. Bycomponent, it is categorized into solutionsand services.On the basis of deployment, it is divided on-premise and cloud. Depending on end user, it is classifiedinto hospitals, office-based physicians, and pharmaceuticals.By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The market players operating in the e-prescribing marketinclude Allscripts Healthcare, LLC, Athenahealth, Inc., Cerner Corporation, Change Healthcare, DrFirst.com, Inc., eClinicalWorks, Epic Systems Corporation, Medical Information Technology, Inc., Practice Fusion, Inc., and Surescripts.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the current & future trends of the market to elucidate the imminent investment pockets.
- Information about key drivers, restraints, and opportunities and their impact analysis on the global e-prescribing market size is provided.
- Porter's five forces analysis illustrates the potency of the buyers and suppliers operating in the global e-prescribing industry.
- The quantitative analysis of the market from 2018 to 2026 is provided to determine the global e-prescribing market potential.
KEY MARKET SEGMENTS
By Component
By Deployment
By End User
- Hospitals
- Office-based Physicians
- Pharmaceuticals
By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- LAMEA
- Latin America
- Middle East
- Africa
KEY MARKET PLAYERS
- Allscripts Healthcare, LLC
- Athenahealth, Inc.
- Cerner Corporation
- Change Healthcare
- DrFirst.com, Inc.
- eClinicalWorks
- Epic Systems Corporation
- Medical Information Technology, Inc.
- Practice Fusion, Inc.
- Surescripts
Table of Contents
CHAPTER 1: INTRODUCTION
- 1.1. REPORT DESCRIPTION
- 1.2. KEY BENEFITS FOR STAKEHOLDERS
- 1.3. KEY MARKET SEGMENTS
- 1.4. KEY MARKET PLAYERS
- 1.5. RESEARCH METHODOLOGY
- 1.5.1. Secondary research
- 1.5.2. Primary research
- 1.5.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. KEY FINDINGS
- 2.1.1. Top impacting factors
- 2.1.2. Top investment pockets
- 2.2. CXO PERSPECTIVE
CHAPTER 3: MARKET OVERVIEW
- 3.1. MARKET DEFINITION AND SCOPE
- 3.2. KEY FORCES SHAPING THE GLOBAL E-PRESCRIBING MARKET
- 3.3. VALUE CHAIN ANALYSIS
- 3.4. MARKET DYNAMICS
- 3.4.1. Drivers
- 3.4.1.1. Government initiatives and incentive programs
- 3.4.1.2. Rise in focus on the reduction of fraud and abuse of controlled substances
- 3.4.1.3. Need to curtail escalating healthcare costs
- 3.4.2. Restraints
- 3.4.2.1. High cost of systems
- 3.4.2.2. Security & workflow issues
- 3.4.3. Opportunities
- 3.4.3.1. Growth in the developing countries across Asia-Pacific
- 3.5. INDUSTRY ROADMAP OF E-PRESCRIBING
- 3.6. IMPACT OF GOVERNMENT REGULATIONS ON THE GLOBAL E-PRESCRIBING MARKET
CHAPTER 4: E-PRESCRIBING MARKET, BY COMPONENT
- 4.1. OVERVIEW
- 4.2. SOLUTIONS
- 4.2.1. Key market trends, growth factors, and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market analysis, by country
- 4.3. SERVICES
- 4.3.1. Key market trends, growth factors, and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market analysis, by country
CHAPTER 5: E-PRESCRIBING MARKET, BY DEPLOYMENT
- 5.1. OVERVIEW
- 5.2. WEB & CLOUD-BASED
- 5.2.1. Key market trends, growth factors, and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market analysis, by country
- 5.3. ON-PREMISE
- 5.3.1. Key market trends, growth factors, and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market analysis, by country
CHAPTER 6: E-PRESCRIBING MARKET, BY END USER
- 6.1. OVERVIEW
- 6.2. HOSPITALS
- 6.2.1. Key market trends, growth factors, and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market analysis, by country
- 6.3. OFFICE-BASED PHYSICIANS
- 6.3.1. Key market trends, growth factors, and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market analysis, by country
- 6.4. PHARMACEUTICALS
- 6.4.1. Key market trends, growth factors, and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market analysis, by country
CHAPTER 7: E-PRESCRIBING MARKET, BY REGION
- 7.1. OVERVIEW
- 7.1.1. Market size and forecast, by region
- 7.2. NORTH AMERICA
- 7.2.1. Key market trends, growth factors, and opportunities
- 7.2.2. Market size and forecast, by component
- 7.2.3. Market size and forecast, by deployment
- 7.2.4. Market size and forecast, by end user
- 7.2.5. Market analysis, by country
- 7.2.5.1. U.S.
- 7.2.5.1.1. Market size and forecast, by component
- 7.2.5.1.2. Market size and forecast, by deployment
- 7.2.5.1.3. Market size and forecast, by end user
- 7.2.5.2. Canada
- 7.2.5.2.1. Market size and forecast, by component
- 7.2.5.2.2. Market size and forecast, by deployment
- 7.2.5.2.3. Market size and forecast, by end user
- 7.3. EUROPE
- 7.3.1. Key market trends, growth factors, and opportunities
- 7.3.2. Market size and forecast, by component
- 7.3.3. Market size and forecast, by deployment
- 7.3.4. Market size and forecast, by end user
- 7.3.5. Market analysis, by country
- 7.3.5.1. Germany
- 7.3.5.1.1. Market size and forecast, by component
- 7.3.5.1.2. Market size and forecast, by deployment
- 7.3.5.1.3. Market size and forecast, by end user
- 7.3.5.2. UK
- 7.3.5.2.1. Market size and forecast, by component
- 7.3.5.2.2. Market size and forecast, by deployment
- 7.3.5.2.3. Market size and forecast, by end user
- 7.3.5.3. France
- 7.3.5.3.1. Market size and forecast, by component
- 7.3.5.3.2. Market size and forecast, by deployment
- 7.3.5.3.3. Market size and forecast, by end user
- 7.3.5.4. Rest of Europe
- 7.3.5.4.1. Market size and forecast, by component
- 7.3.5.4.2. Market size and forecast, by deployment
- 7.3.5.4.3. Market size and forecast, by end user
- 7.4. ASIA-PACIFIC
- 7.4.1. Key market trends, growth factors, and opportunities
- 7.4.2. Market size and forecast, by component
- 7.4.3. Market size and forecast, by deployment
- 7.4.4. Market size and forecast, by end user
- 7.4.5. Market analysis, by country
- 7.4.5.1. Japan
- 7.4.5.1.1. Market size and forecast, by component
- 7.4.5.1.2. Market size and forecast, by deployment
- 7.4.5.1.3. Market size and forecast, by end user
- 7.4.5.2. China
- 7.4.5.2.1. Market size and forecast, by component
- 7.4.5.2.2. Market size and forecast, by deployment
- 7.4.5.2.3. Market size and forecast, by end user
- 7.4.5.3. India
- 7.4.5.3.1. Market size and forecast, by component
- 7.4.5.3.2. Market size and forecast, by deployment
- 7.4.5.3.3. Market size and forecast, by end user
- 7.4.5.4. Rest of Asia-Pacific
- 7.4.5.4.1. Market size and forecast, by component
- 7.4.5.4.2. Market size and forecast, by deployment
- 7.4.5.4.3. Market size and forecast, by end user
- 7.5. LAMEA
- 7.5.1. Key market trends, growth factors, and opportunities
- 7.5.2. Market size and forecast, by component
- 7.5.3. Market size and forecast, by deployment
- 7.5.4. Market size and forecast, by end user
- 7.5.5. Market analysis, by country
- 7.5.5.1. Latin America
- 7.5.5.1.1. Market size and forecast, by component
- 7.5.5.1.2. Market size and forecast, by deployment
- 7.5.5.1.3. Market size and forecast, by end user
- 7.5.5.2. Middle East
- 7.5.5.2.1. Market size and forecast, by component
- 7.5.5.2.2. Market size and forecast, by deployment
- 7.5.5.2.3. Market size and forecast, by end user
- 7.5.5.3. Africa
- 7.5.5.3.1. Market size and forecast, by component
- 7.5.5.3.2. Market size and forecast, by deployment
- 7.5.5.3.3. Market size and forecast, by end user
CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. KEY PLAYERS POSITIONING ANALYSIS, 2018
- 8.2. TOP WINNING STRATEGIES
- 8.3. KEY DEVELOPMENTS
- 8.3.1. Product launches
- 8.3.2. Partnership
- 8.3.3. Business expansion
- 8.3.4. Acquisition
- 8.3.5. Collaboration
- 8.4. PATENT ANALYSIS
- 8.4.1. By region (2016-2019)
- 8.4.2. By applicant
CHAPTER 9: COMPANY PROFILE
- 9.1. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
- 9.1.1. Company overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. R&D Expenditure
- 9.1.7. Business performance
- 9.1.8. Key strategic moves and developments
- 9.2. ATHENAHEALTH, INC.
- 9.2.1. Company overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
- 9.2.4. Product portfolio
- 9.2.5. Key strategic moves and developments
- 9.3. CERNER CORPORATION
- 9.3.1. Company overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
- 9.3.4. Product portfolio
- 9.3.5. Business performance
- 9.3.6. Key strategic moves and developments
- 9.4. CHANGE HEALTHCARE
- 9.4.1. Company overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
- 9.4.4. Product portfolio
- 9.4.5. Key strategic moves and developments
- 9.5. DRFIRST
- 9.5.1. Company overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
- 9.5.4. Product portfolio
- 9.5.5. Key strategic moves and developments
- 9.6. ECLINICALWORKS
- 9.6.1. Company overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
- 9.6.4. Product portfolio
- 9.6.5. Key strategic moves and developments
- 9.7. EPIC SYSTEMS CORPORATION
- 9.7.1. Company overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
- 9.7.4. Product portfolio
- 9.7.5. Key strategic moves and developments
- 9.8. MEDICAL INFORMATION TECHNOLOGY, INC.
- 9.8.1. Company overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
- 9.8.4. Product portfolio
- 9.8.5. Key strategic moves and developments
- 9.9. PRACTICE FUSION, INC.
- 9.9.1. Company overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
- 9.9.4. Product portfolio
- 9.9.5. Key strategic moves and developments
- 9.10. SURESCRIPTS
- 9.10.1. Company overview
- 9.10.2. Key Executives
- 9.10.3. Company snapshot
- 9.10.4. Product portfolio
- 9.10.5. Key strategic moves and developments
LIST OF TABLES
- TABLE 01. E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
- TABLE 02. E-PRESCRIBING MARKET REVENUE FOR SOLUTIONS, BY REGION 2018-2026 ($MILLION)
- TABLE 03. E-PRESCRIBING MARKET REVENUE FOR SERVICES, BY REGION 2018-2026 ($MILLION)
- TABLE 04. E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
- TABLE 05. E-PRESCRIBING MARKET REVENUE FOR WEB & CLOUD-BASED, BY REGION 2018-2026 ($MILLION)
- TABLE 06. E-PRESCRIBING MARKET REVENUE FOR ON-PREMISE, BY REGION 2018-2026 ($MILLION)
- TABLE 07. GLOBAL E-PRESCRIBING MARKET, BY END USER, 2018-2026 ($MILLION)
- TABLE 08. E-PRESCRIBING MARKET REVENUE FOR HOSPITALS, BY REGION, 2018-2026 ($MILLION)
- TABLE 09. E-PRESCRIBING MARKET REVENUE FOR OFFICE-BASED PHYSICIANS, BY REGION, 2018-2026 ($MILLION)
- TABLE 10. E-PRESCRIBING MARKET REVENUE FOR PHARMACEUTICALS, BY REGION, 2018-2026 ($MILLION)
- TABLE 11. GLOBAL E-PRESCRIBING MARKET REVENUE, BY REGION, 2018-2026 ($MILLION)
- TABLE 12. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
- TABLE 13. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018-2026 ($MILLION)
- TABLE 14. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
- TABLE 15. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018-2026 ($MILLION)
- TABLE 16. U.S. E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
- TABLE 17. U.S. E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
- TABLE 18. U.S. E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
- TABLE 19. CANADA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
- TABLE 20. CANADA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
- TABLE 21. CANADA E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
- TABLE 22. EUROPE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
- TABLE 23. EUROPE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018-2026 ($MILLION)
- TABLE 24. EUROPE E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
- TABLE 25. EUROPE E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018-2026 ($MILLION)
- TABLE 26. GERMANY E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
- TABLE 27. GERMANY E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
- TABLE 28. GERMANY E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
- TABLE 29. UK E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
- TABLE 30. UK E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
- TABLE 31. UK E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
- TABLE 32. FRANCE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
- TABLE 33. FRANCE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
- TABLE 34. FRANCE E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
- TABLE 35. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
- TABLE 36. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
- TABLE 37. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
- TABLE 38. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
- TABLE 39. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018-2026 ($MILLION)
- TABLE 40. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
- TABLE 41. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018-2026 ($MILLION)
- TABLE 42. JAPAN E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
- TABLE 43. JAPAN E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
- TABLE 44. JAPAN E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
- TABLE 45. CHINA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
- TABLE 46. CHINA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
- TABLE 47. CHINA E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
- TABLE 48. INDIA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
- TABLE 49. INDIA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
- TABLE 50. INDIA E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
- TABLE 51. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
- TABLE 52. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
- TABLE 53. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
- TABLE 54. LAMEA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
- TABLE 55. LAMEA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018-2026 ($MILLION)
- TABLE 56. LAMEA E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
- TABLE 57. LAMEA E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018-2026 ($MILLION)
- TABLE 58. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
- TABLE 59. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
- TABLE 60. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
- TABLE 61. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
- TABLE 62. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
- TABLE 63. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
- TABLE 64. AFRICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
- TABLE 65. AFRICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018-2026 ($MILLION)
- TABLE 66. AFRICA E-PRESCRIBING MARKET REVENUE, BY END USER 2018-2026 ($MILLION)
- TABLE 67. KEY NEW PRODUCT LAUNCHES (2016-2019)
- TABLE 68. PARTNERSHIP (2016-2019)
- TABLE 69. KEY EXPANSION (2016-2019)
- TABLE 70. KEY ACQUISITION (2016-2019)
- TABLE 71. COLLABORATION (2016-2019)
- TABLE 72. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: KEY EXECUTIVES
- TABLE 73. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT
- TABLE 74. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: OPERATING SEGMENTS
- TABLE 75. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: PRODUCT PORTFOLIO
- TABLE 76. ATHENAHEALTH, INC.: KEY EXECUTIVES
- TABLE 77. ATHENAHEALTH, INC.: COMPANY SNAPSHOT
- TABLE 78. ATHENAHEALTH, INC.: PRODUCT PORTFOLIO
- TABLE 79. CERNER CORPORATION: KEY EXECUTIVES
- TABLE 80. CERNER CORPORATION: COMPANY SNAPSHOT
- TABLE 81. CERNER CORPORATION: PRODUCT PORTFOLIO
- TABLE 82. CHANGE HEALTHCARE: KEY EXECUTIVES
- TABLE 83. CHANGE HEALTHCARE: COMPANY SNAPSHOT
- TABLE 84. CHANGE HEALTHCARE: PRODUCT PORTFOLIO
- TABLE 85. DRFIRST: KEY EXECUTIVES
- TABLE 86. DRFIRST: COMPANY SNAPSHOT
- TABLE 87. DRFIRST: PRODUCT PORTFOLIO
- TABLE 88. ECLINICALWORKS: KEY EXECUTIVES
- TABLE 89. ECLINICALWORKS: COMPANY SNAPSHOT
- TABLE 90. ECLINICALWORKS: PRODUCT PORTFOLIO
- TABLE 91. EPIC SYSTEMS CORPORATION: KEY EXECUTIVES
- TABLE 92. EPIC SYSTEMS CORPORATION: COMPANY SNAPSHOT
- TABLE 93. EPIC SYSTEMS CORPORATION: PRODUCT PORTFOLIO
- TABLE 94. MEDICAL INFORMATION TECHNOLOGY, INC.: KEY EXECUTIVES
- TABLE 95. MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY SNAPSHOT
- TABLE 96. MEDICAL INFORMATION TECHNOLOGY, INC.: PRODUCT PORTFOLIO
- TABLE 97. PRACTICE FUSION, INC.: KEY EXECUTIVES
- TABLE 98. PRACTICE FUSION, INC.: COMPANY SNAPSHOT
- TABLE 99. PRACTICE FUSION, INC.: PRODUCT PORTFOLIO
- TABLE 100. SURESCRIPTS: KEY EXECUTIVES
- TABLE 101. SURESCRIPTS: COMPANY SNAPSHOT
- TABLE 102. SURESCRIPTS: PRODUCT PORTFOLIO
LIST OF FIGURES
- FIGURE 01. KEY MARKET SEGMENTS
- FIGURE 02. GLOBAL E-PRESCRIBING MARKET, 2018-2026
- FIGURE 03. GLOBAL E-PRESCRIBING MARKET, BY REGION, 2018-2026
- FIGURE 04. TOP IMPACTING FACTORS
- FIGURE 05. TOP INVESTMENT POCKETS
- FIGURE 06. TOP PLAYERS OF THE GLOBAL E-PRESCRIBING MARKET
- FIGURE 07. MODERATE-TO-HIGH BARGAINING POWER OF SUPPLIERS
- FIGURE 08. MODERATE-TO-HIGH BARGAINING POWER OF BUYER
- FIGURE 09. MODERATE-TO-HIGH THREAT OF SUBSTITUTES
- FIGURE 10. MODERATE-TO-HIGH THREAT OF NEW ENTRANTS
- FIGURE 11. LOW-TO-HIGH COMPETITIVE RIVALRY
- FIGURE 12. VALUE CHAIN ANALYSIS OF E-PRESCRIBING MARKET
- FIGURE 13. MARKET DYNAMICS: GLOBAL E-PRESCRIBING MARKET
- FIGURE 14. INDUSTRY ROADMAP OF E-PRESCRIBING
- FIGURE 15. GLOBAL E-PRESCRIBING MARKET, BY COMPONENT, 2018-2026
- FIGURE 16. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR SOLUTIONS, BY COUNTRY, 2018 & 2026 (%)
- FIGURE 17. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR SERVICES, BY COUNTRY, 2018 & 2026 (%)
- FIGURE 18. GLOBAL E-PRESCRIBING MARKET, BY DEPLOYMENT, 2018-2025
- FIGURE 19. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR WEB & CLOUD-BASED, BY COUNTRY, 2018 & 2026 (%)
- FIGURE 20. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR ON-PREMISE, BY COUNTRY, 2018 & 2026 (%)
- FIGURE 21. GLOBAL E-PRESCRIBING MARKET REVENUE, BY END USER, 2018-2026 ($MILLION)
- FIGURE 22. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR HOSPITALS, BY COUNTRY, 2018 & 2026 (%)
- FIGURE 23. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR OFFICE-BASED PHYSICIANS, BY COUNTRY, 2018 & 2026 (%)
- FIGURE 24. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2018 & 2026 (%)
- FIGURE 25. GLOBAL E-PRESCRIBING MARKET REVENUE, BY REGION, 2018-2026 ($MILLION)
- FIGURE 26. U.S. E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
- FIGURE 27. CANADA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
- FIGURE 28. GERMANY E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
- FIGURE 29. UK E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
- FIGURE 30. FRANCE E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
- FIGURE 31. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
- FIGURE 32. JAPAN E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
- FIGURE 33. CHINA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
- FIGURE 34. INDIA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
- FIGURE 35. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
- FIGURE 36. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
- FIGURE 37. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
- FIGURE 38. AFRICA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
- FIGURE 39. KEY PLAYER POSITIONING ANLYSIS: GLOBAL E-PRESCRIBING MARKET
- FIGURE 40. TOP WINNING STRATEGIES, BY YEAR, 2016-2019
- FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2019
- FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY, 2016-2019
- FIGURE 43. PATENT ANALYSIS, BY REGION
- FIGURE 44. PATENT ANALYSIS, BY APPLICANT
- FIGURE 45. R&D EXPENDITURE, 2016-2018 ($MILLION)
- FIGURE 46. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE, 2016-2018 ($MILLION)
- FIGURE 47. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE SHARE BY SEGMENT, 2018 (%)
- FIGURE 48. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE SHARE BY REGION, 2018 (%)
- FIGURE 49. CERNER CORPORATION: REVENUE, 2016-2018 ($MILLION)
- FIGURE 50. CERNER CORPORATION: REVENUE SHARE BY REGION, 2018 (%)
